Establishing an Anticoagulation “Drive Through” Clinic during the COVID-19 Pandemic using the LumiraDx Platform INR Test
An evaluation of the detection of SARS-CoV-2 antigen in a cohort of symptomatic and asymptomatic patients: Report from the evaluation of SKUP
Performance evaluation of the LumiraDx SARS-CoV-2 Antigen Test to aid diagnosis of acute COVID-19 at the point of care
Evaluation of the Accuracy of the LumiraDx INR Test Using Patients in Receipt of Phenprocoumon Anticoagulation Therapy
Evaluation of the Accuracy of INR values measured by a POCT system in a German Clinic with patients taking Phenprocoumon as VKA Therapy.
Laboratory accuracy assessment of a novel INR Point-of-Care Test compared with laboratory reference methods used across four independent clinical sites.
Evaluation der Genauigkeit von LumiraDx INR-Messwerten bei Patienten unter Phenprocoumon-Therapie.
Sensitivity of LumiraDx INR Testing to Interference from Antiphospholipid Antibodies (aPL)
The LumiraDx Platform INR Test: Performance and ease of use in an anticoagulation clinic setting
LumiraDx INR Test: Laboratory Accuracy Assessment with the ACL Elite and Sysmex Reference Methods
Produktevaluation der LumiraDx Platform und des INR-Tests durch die Arztpraxis Dres. Schreiber, Steinbauer & Dechant
Performance of the LumiraDx Platform INR Test in a point-of-care setting compared to an established laboratory reference method
Point of care testing in primary care in Europe: Improving pathways and patient outcomes
Point-of-care testing in the community pharmacy – improving access to care.
Summary of the Evaluation of 32 rapid tests for detection of IgG antibodies against SARS-CoV-2 (NOKLUS)